NEOBE THERAPEUTICS LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Neobe Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Neobe Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NEOBE THERAPEUTICS LTD is an active private limited company (company number 13146056) incorporated on 20 January 2021, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £228k and cash of £37k, with 8 employees on average. Net assets fell 67% on the prior period (£694k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the upper half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
No active person with significant control is registered.
- Dr. Pedro Vaz De Almada Correa De Sampaio
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr. Annelise Juliette Soulier
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 20 January 20215 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 3 February 2027in 99 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £228k | £37k | — | £46k | — | — | 8 |
| 31 December 2024 | £694k | £440k | — | £137k | — | — | 6 |
| 31 January 2024 | £1.13m | £1.04m | — | £50k | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £227,914 at 31 December 2025
- Net assets down 25% or more on the prior period-67.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.84
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 20 January 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 338 days
- Confirmation statement duein 99 days
- Accounts period endNet assets £228k · small accounts
- Accounts period endNet assets £694k · small accounts
- Accounts period endNet assets £1.13m · small accounts
- Incorporated
Similar companies in Cambridge
- CAMBRIDGE NUCLEOMICS LTDCambridge · inc. Jan 2021
- VIVAVACS LIMITEDCambridge · inc. Feb 2021
- STINGRAY BIO LIMITEDCambridge · inc. Dec 2020
- VIROLOGICA LIMITEDCambridge · inc. Dec 2020
- CENENTRY BIOSCIENCES LIMITEDCambridge · inc. Mar 2021
- 4BASEBIO DISCOVERY LIMITEDCambridge · inc. Oct 2020
All companies incorporated on 20 January 2021 · in Jan 2021.
Reminders for NEOBE THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.